This brand name is authorized in Estonia, Lithuania, Poland, South Africa.
The drug HELIXATE contains one active pharmaceutical ingredient (API):
1
|
UNII
5T6B772R4Q - HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX
|
|
Octocog alfa (Full length recombinant human coagulation factor VIII (rDNA)) is a purified protein that has 2,332 amino acids. It is produced by recombinant DNA technology in baby hamster kidney cells (BHK) into which the human factor VIII gene has been introduced. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| B02BD02 | Coagulation factor VIII | B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1203084, 1203095, 1203107, 1364509, 1489091 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1028762, 1028763, 1028764, 1031804, 1056128 |
| PL | Rejestru Produktów Leczniczych | 100127200, 100127217, 100127223, 100309987, 100309993 |
| ZA | Health Products Regulatory Authority | 31/8.1/0270, 31/8.1/0271, 31/8.1/0272 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.